![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: AP2A1 |
Gene summary for AP2A1 |
![]() |
Gene information | Species | Human | Gene symbol | AP2A1 | Gene ID | 160 |
Gene name | adaptor related protein complex 2 subunit alpha 1 | |
Gene Alias | ADTAA | |
Cytomap | 19q13.33 | |
Gene Type | protein-coding | GO ID | GO:0000271 | UniProtAcc | O95782 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
160 | AP2A1 | LZE4T | Human | Esophagus | ESCC | 1.28e-06 | 1.51e-01 | 0.0811 |
160 | AP2A1 | LZE7T | Human | Esophagus | ESCC | 2.12e-07 | 4.39e-01 | 0.0667 |
160 | AP2A1 | LZE8T | Human | Esophagus | ESCC | 8.64e-04 | 1.49e-01 | 0.067 |
160 | AP2A1 | LZE20T | Human | Esophagus | ESCC | 1.11e-02 | 2.09e-01 | 0.0662 |
160 | AP2A1 | LZE22T | Human | Esophagus | ESCC | 9.28e-05 | 4.86e-01 | 0.068 |
160 | AP2A1 | LZE24T | Human | Esophagus | ESCC | 2.34e-25 | 5.92e-01 | 0.0596 |
160 | AP2A1 | LZE21T | Human | Esophagus | ESCC | 1.11e-03 | 2.25e-01 | 0.0655 |
160 | AP2A1 | LZE6T | Human | Esophagus | ESCC | 1.34e-04 | 2.74e-01 | 0.0845 |
160 | AP2A1 | P1T-E | Human | Esophagus | ESCC | 1.30e-14 | 7.74e-01 | 0.0875 |
160 | AP2A1 | P2T-E | Human | Esophagus | ESCC | 2.18e-21 | 3.70e-01 | 0.1177 |
160 | AP2A1 | P4T-E | Human | Esophagus | ESCC | 6.38e-16 | 3.63e-01 | 0.1323 |
160 | AP2A1 | P5T-E | Human | Esophagus | ESCC | 3.29e-08 | 1.79e-01 | 0.1327 |
160 | AP2A1 | P8T-E | Human | Esophagus | ESCC | 2.01e-51 | 8.56e-01 | 0.0889 |
160 | AP2A1 | P9T-E | Human | Esophagus | ESCC | 7.19e-13 | 2.50e-01 | 0.1131 |
160 | AP2A1 | P10T-E | Human | Esophagus | ESCC | 1.65e-23 | 4.77e-01 | 0.116 |
160 | AP2A1 | P11T-E | Human | Esophagus | ESCC | 8.81e-27 | 9.57e-01 | 0.1426 |
160 | AP2A1 | P12T-E | Human | Esophagus | ESCC | 5.76e-27 | 5.09e-01 | 0.1122 |
160 | AP2A1 | P15T-E | Human | Esophagus | ESCC | 6.53e-32 | 6.54e-01 | 0.1149 |
160 | AP2A1 | P16T-E | Human | Esophagus | ESCC | 6.62e-15 | 1.91e-01 | 0.1153 |
160 | AP2A1 | P17T-E | Human | Esophagus | ESCC | 2.05e-13 | 6.51e-01 | 0.1278 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004819318 | Esophagus | ESCC | Golgi vesicle transport | 231/8552 | 296/18723 | 1.82e-30 | 9.63e-28 | 231 |
GO:001648210 | Esophagus | ESCC | cytosolic transport | 124/8552 | 168/18723 | 9.69e-14 | 4.69e-12 | 124 |
GO:000689215 | Esophagus | ESCC | post-Golgi vesicle-mediated transport | 82/8552 | 104/18723 | 4.00e-12 | 1.55e-10 | 82 |
GO:003010018 | Esophagus | ESCC | regulation of endocytosis | 135/8552 | 211/18723 | 5.75e-08 | 1.02e-06 | 135 |
GO:004580718 | Esophagus | ESCC | positive regulation of endocytosis | 69/8552 | 100/18723 | 1.97e-06 | 2.29e-05 | 69 |
GO:003134616 | Esophagus | ESCC | positive regulation of cell projection organization | 201/8552 | 353/18723 | 1.19e-05 | 1.11e-04 | 201 |
GO:000689818 | Esophagus | ESCC | receptor-mediated endocytosis | 142/8552 | 244/18723 | 5.22e-05 | 4.05e-04 | 142 |
GO:007258314 | Esophagus | ESCC | clathrin-dependent endocytosis | 34/8552 | 47/18723 | 1.91e-04 | 1.21e-03 | 34 |
GO:001097516 | Esophagus | ESCC | regulation of neuron projection development | 240/8552 | 445/18723 | 2.48e-04 | 1.53e-03 | 240 |
GO:00160514 | Esophagus | ESCC | carbohydrate biosynthetic process | 117/8552 | 202/18723 | 2.96e-04 | 1.79e-03 | 117 |
GO:004825916 | Esophagus | ESCC | regulation of receptor-mediated endocytosis | 66/8552 | 110/18723 | 1.72e-03 | 7.96e-03 | 66 |
GO:00061096 | Esophagus | ESCC | regulation of carbohydrate metabolic process | 101/8552 | 178/18723 | 1.89e-03 | 8.52e-03 | 101 |
GO:004826010 | Esophagus | ESCC | positive regulation of receptor-mediated endocytosis | 34/8552 | 52/18723 | 3.26e-03 | 1.35e-02 | 34 |
GO:00109764 | Esophagus | ESCC | positive regulation of neuron projection development | 91/8552 | 163/18723 | 5.72e-03 | 2.13e-02 | 91 |
GO:0006024 | Esophagus | ESCC | glycosaminoglycan biosynthetic process | 45/8552 | 75/18723 | 8.75e-03 | 3.08e-02 | 45 |
GO:0006023 | Esophagus | ESCC | aminoglycan biosynthetic process | 47/8552 | 79/18723 | 9.29e-03 | 3.23e-02 | 47 |
GO:00068953 | Esophagus | ESCC | Golgi to endosome transport | 13/8552 | 17/18723 | 1.00e-02 | 3.42e-02 | 13 |
GO:004819321 | Liver | HCC | Golgi vesicle transport | 217/7958 | 296/18723 | 2.58e-27 | 1.02e-24 | 217 |
GO:001648221 | Liver | HCC | cytosolic transport | 117/7958 | 168/18723 | 8.83e-13 | 4.48e-11 | 117 |
GO:000689221 | Liver | HCC | post-Golgi vesicle-mediated transport | 77/7958 | 104/18723 | 6.14e-11 | 2.24e-09 | 77 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05016210 | Esophagus | ESCC | Huntington disease | 226/4205 | 306/8465 | 1.38e-18 | 8.72e-17 | 4.46e-17 | 226 |
hsa04144210 | Esophagus | ESCC | Endocytosis | 186/4205 | 251/8465 | 9.74e-16 | 4.66e-14 | 2.39e-14 | 186 |
hsa0501638 | Esophagus | ESCC | Huntington disease | 226/4205 | 306/8465 | 1.38e-18 | 8.72e-17 | 4.46e-17 | 226 |
hsa0414437 | Esophagus | ESCC | Endocytosis | 186/4205 | 251/8465 | 9.74e-16 | 4.66e-14 | 2.39e-14 | 186 |
hsa0501622 | Liver | HCC | Huntington disease | 219/4020 | 306/8465 | 3.06e-18 | 3.42e-16 | 1.90e-16 | 219 |
hsa0414422 | Liver | HCC | Endocytosis | 178/4020 | 251/8465 | 2.03e-14 | 5.22e-13 | 2.91e-13 | 178 |
hsa0501632 | Liver | HCC | Huntington disease | 219/4020 | 306/8465 | 3.06e-18 | 3.42e-16 | 1.90e-16 | 219 |
hsa0414432 | Liver | HCC | Endocytosis | 178/4020 | 251/8465 | 2.03e-14 | 5.22e-13 | 2.91e-13 | 178 |
hsa0414427 | Oral cavity | OSCC | Endocytosis | 174/3704 | 251/8465 | 9.42e-17 | 4.51e-15 | 2.29e-15 | 174 |
hsa0501628 | Oral cavity | OSCC | Huntington disease | 204/3704 | 306/8465 | 1.70e-16 | 7.13e-15 | 3.63e-15 | 204 |
hsa04144112 | Oral cavity | OSCC | Endocytosis | 174/3704 | 251/8465 | 9.42e-17 | 4.51e-15 | 2.29e-15 | 174 |
hsa05016112 | Oral cavity | OSCC | Huntington disease | 204/3704 | 306/8465 | 1.70e-16 | 7.13e-15 | 3.63e-15 | 204 |
hsa0501629 | Oral cavity | LP | Huntington disease | 172/2418 | 306/8465 | 6.31e-25 | 5.25e-23 | 3.39e-23 | 172 |
hsa0414428 | Oral cavity | LP | Endocytosis | 121/2418 | 251/8465 | 1.89e-11 | 3.70e-10 | 2.38e-10 | 121 |
hsa0501637 | Oral cavity | LP | Huntington disease | 172/2418 | 306/8465 | 6.31e-25 | 5.25e-23 | 3.39e-23 | 172 |
hsa0414436 | Oral cavity | LP | Endocytosis | 121/2418 | 251/8465 | 1.89e-11 | 3.70e-10 | 2.38e-10 | 121 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AP2A1 | SNV | Missense_Mutation | rs762300764 | c.566N>T | p.Thr189Met | p.T189M | O95782 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-PN-A8MA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
AP2A1 | SNV | Missense_Mutation | c.831G>C | p.Lys277Asn | p.K277N | O95782 | protein_coding | deleterious(0) | possibly_damaging(0.601) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
AP2A1 | SNV | Missense_Mutation | novel | c.2927A>G | p.Gln976Arg | p.Q976R | O95782 | protein_coding | tolerated(0.28) | possibly_damaging(0.893) | TCGA-UC-A7PI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
AP2A1 | SNV | Missense_Mutation | c.1924N>T | p.Gly642Trp | p.G642W | O95782 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-A6-2686-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
AP2A1 | SNV | Missense_Mutation | c.154N>T | p.Gly52Cys | p.G52C | O95782 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-A01R-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fluorouracil | PD | |
AP2A1 | SNV | Missense_Mutation | c.1612N>T | p.Arg538Trp | p.R538W | O95782 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AZ-4313-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
AP2A1 | SNV | Missense_Mutation | novel | c.310T>C | p.Ser104Pro | p.S104P | O95782 | protein_coding | deleterious(0.02) | probably_damaging(0.987) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
AP2A1 | SNV | Missense_Mutation | c.1036N>T | p.Arg346Cys | p.R346C | O95782 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
AP2A1 | SNV | Missense_Mutation | novel | c.2452N>A | p.Gly818Ser | p.G818S | O95782 | protein_coding | tolerated(0.34) | benign(0.336) | TCGA-CM-4744-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
AP2A1 | SNV | Missense_Mutation | c.1391G>A | p.Arg464His | p.R464H | O95782 | protein_coding | deleterious(0.01) | probably_damaging(0.989) | TCGA-G4-6309-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | xeloda | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |